- Home
- CRDL vs DIT Comparison
CRDL vs DIT Comparison
Compare CRDL & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- DIT
- Stock Information
- Founded
- CRDL 2017
- DIT 1981
- Country
- CRDL Canada
- DIT United States
- Employees
- CRDL N/A
- DIT N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- DIT Food Distributors
- Sector
- CRDL Health Care
- DIT Consumer Discretionary
- Exchange
- CRDL Nasdaq
- DIT Nasdaq
- Market Cap
- CRDL 90.4M
- DIT 76.6M
- IPO Year
- CRDL N/A
- DIT 1995
- Fundamental
- Price
- CRDL $1.22
- DIT $114.00
- Analyst Decision
- CRDL Strong Buy
- DIT
- Analyst Count
- CRDL 2
- DIT 0
- Target Price
- CRDL $9.00
- DIT N/A
- AVG Volume (30 Days)
- CRDL 859.1K
- DIT 327.0
- Earning Date
- CRDL 11-13-2025
- DIT 11-07-2025
- Dividend Yield
- CRDL N/A
- DIT 0.88%
- EPS Growth
- CRDL N/A
- DIT N/A
- EPS
- CRDL N/A
- DIT 2.14
- Revenue
- CRDL N/A
- DIT $2,251,684,195.00
- Revenue This Year
- CRDL N/A
- DIT N/A
- Revenue Next Year
- CRDL N/A
- DIT N/A
- P/E Ratio
- CRDL N/A
- DIT $53.26
- Revenue Growth
- CRDL N/A
- DIT 7.64
- 52 Week Low
- CRDL $0.77
- DIT $94.92
- 52 Week High
- CRDL $2.24
- DIT $163.75
- Technical
- Relative Strength Index (RSI)
- CRDL 63.48
- DIT 43.11
- Support Level
- CRDL $1.01
- DIT $115.02
- Resistance Level
- CRDL $1.38
- DIT $119.40
- Average True Range (ATR)
- CRDL 0.08
- DIT 2.37
- MACD
- CRDL 0.02
- DIT -0.27
- Stochastic Oscillator
- CRDL 58.60
- DIT 19.55
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.